FI922356A - Vaesentligen rent humant paratyroidhormon - Google Patents

Vaesentligen rent humant paratyroidhormon Download PDF

Info

Publication number
FI922356A
FI922356A FI922356A FI922356A FI922356A FI 922356 A FI922356 A FI 922356A FI 922356 A FI922356 A FI 922356A FI 922356 A FI922356 A FI 922356A FI 922356 A FI922356 A FI 922356A
Authority
FI
Finland
Prior art keywords
vaesentligen
paratyroidhormon
humant
rent
parathyroid hormone
Prior art date
Application number
FI922356A
Other languages
English (en)
Other versions
FI106802B (fi
FI922356A0 (fi
Inventor
Dennis R Sindrey
Original Assignee
Allelix Biopharma
Glaxo Canada
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24840399&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI922356(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Allelix Biopharma, Glaxo Canada filed Critical Allelix Biopharma
Publication of FI922356A0 publication Critical patent/FI922356A0/fi
Publication of FI922356A publication Critical patent/FI922356A/fi
Application granted granted Critical
Publication of FI106802B publication Critical patent/FI106802B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/635—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Steroid Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
FI922356A 1991-05-23 1992-05-22 Olennaisesti puhdas ihmisen lisäkilpirauhashormoni FI106802B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/707,114 US5208041A (en) 1991-05-23 1991-05-23 Essentially pure human parathyroid hormone
US70711491 1991-05-23

Publications (3)

Publication Number Publication Date
FI922356A0 FI922356A0 (fi) 1992-05-22
FI922356A true FI922356A (fi) 1992-11-24
FI106802B FI106802B (fi) 2001-04-12

Family

ID=24840399

Family Applications (1)

Application Number Title Priority Date Filing Date
FI922356A FI106802B (fi) 1991-05-23 1992-05-22 Olennaisesti puhdas ihmisen lisäkilpirauhashormoni

Country Status (16)

Country Link
US (1) US5208041A (fi)
EP (1) EP0515228B1 (fi)
JP (1) JP2563726B2 (fi)
KR (1) KR970007755B1 (fi)
AT (1) ATE164394T1 (fi)
CA (1) CA2068438C (fi)
DE (1) DE69224858T2 (fi)
DK (1) DK0515228T3 (fi)
ES (1) ES2115642T3 (fi)
FI (1) FI106802B (fi)
HK (1) HK1004340A1 (fi)
IE (1) IE921672A1 (fi)
IL (3) IL119840A (fi)
NO (2) NO304190B1 (fi)
NZ (1) NZ242855A (fi)
ZA (1) ZA923735B (fi)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5420242A (en) * 1986-10-22 1995-05-30 Kaare M. Gautvik Production of human parathyroid hormone from microorganisms
USRE37919E1 (en) 1989-05-12 2002-12-03 The General Hospital Corporation Recombinant DNA method for production of parathyroid hormone
AU8002994A (en) * 1993-10-27 1995-05-22 Chugai Seiyaku Kabushiki Kaisha Cure accelerator in chondroplasty
US6074840A (en) 1994-02-18 2000-06-13 The Regents Of The University Of Michigan Recombinant production of latent TGF-beta binding protein-3 (LTBP-3)
US5763416A (en) 1994-02-18 1998-06-09 The Regent Of The University Of Michigan Gene transfer into bone cells and tissues
US5962427A (en) 1994-02-18 1999-10-05 The Regent Of The University Of Michigan In vivo gene transfer methods for wound healing
US5942496A (en) 1994-02-18 1999-08-24 The Regent Of The University Of Michigan Methods and compositions for multiple gene transfer into bone cells
US20020193338A1 (en) * 1994-02-18 2002-12-19 Goldstein Steven A. In vivo gene transfer methods for wound healing
US6551618B2 (en) 1994-03-15 2003-04-22 University Of Birmingham Compositions and methods for delivery of agents for neuronal regeneration and survival
US7923250B2 (en) 1997-07-30 2011-04-12 Warsaw Orthopedic, Inc. Methods of expressing LIM mineralization protein in non-osseous cells
WO1999006563A1 (en) 1997-07-30 1999-02-11 Emory University Novel bone mineralization proteins, dna, vectors, expression systems
US6770623B1 (en) * 1997-12-09 2004-08-03 Eli Lilly And Company Stabilized teriparatide solutions
AR033639A1 (es) 1998-08-19 2004-01-07 Lilly Co Eli Uso de hormonas paratiroideas para preparar medicamentos para reducir el riesgo de fracturas oseas vertebrales o no vertebrales en seres humanos con riesgo de padecer o que padecen osteoporosis
US6495662B1 (en) * 1998-10-22 2002-12-17 The General Hospital Corporation Bioactive peptides and peptide derivatives of parathyroid hormone (PTH) and parathyroid hormone-related peptide (PTHrP)
AU4217299A (en) * 1998-11-30 2000-06-19 General Hospital Corporation, The Pth1r and pth3r receptors, methods and uses thereof
US7820393B2 (en) * 1999-01-14 2010-10-26 Scantibodies Laboratory, Inc. Methods, kits and antibodies for detecting parathyroid hormone
US6689566B1 (en) * 1999-01-14 2004-02-10 Scantibodies Laboratory, Inc. Methods, kits, and antibodies for detecting parathyroid hormone
US7893021B2 (en) * 1999-06-02 2011-02-22 Scantibodies Laboratory, Inc. Parathyroid hormone antagonists and uses thereof
US20080108086A1 (en) * 1999-06-02 2008-05-08 Cantor Thomas L Parathyroid hormone antagonists and uses thereof
WO2001023521A2 (en) * 1999-09-29 2001-04-05 The General Hospital Corporation Polypeptide derivatives of parathyroid hormone (pth)
IL153678A0 (en) 2000-06-30 2003-07-06 Suntory Ltd A pharmaceutical component comprising a human parathyroid hormone
US6387711B1 (en) * 2000-08-11 2002-05-14 Quest Diagnostics Investments Incorporated Liquid intact parathyroid hormone (PTH) standards
US6905886B2 (en) * 2000-08-11 2005-06-14 Quest Diagnostics Investments Incorporated Preservative solutions
JP4837888B2 (ja) * 2001-07-23 2011-12-14 ザ ジェネラル ホスピタル コーポレイション コンホメーションが拘束された副甲状腺ホルモン（ｐｔｈ）類似体
US20040067526A1 (en) * 2002-10-03 2004-04-08 Cantor Thomas L. Methods for diagnosing and guiding treatment of bone turnover disease
EP1610813A4 (en) * 2003-03-19 2009-07-01 Gen Hospital Corp PARATHYROIDAL HORMONES CONFORMALLY CONFORMALLY CONSTRAINED WITH PROPELLER STABILIZERS $ G (A)
KR100540659B1 (ko) * 2003-07-02 2006-01-10 삼성전자주식회사 이미지 확대 인쇄 방법과 장치 및 컴퓨터 프로그램을저장하는 컴퓨터로 읽을 수 있는 기록 매체
WO2005009358A2 (en) 2003-07-17 2005-02-03 The General Hospital Corporation Conformationally constrained parathyroid hormone (pth) analogs
AU2005244734A1 (en) 2004-05-13 2005-12-01 Alza Corporation Apparatus and method for transdermal delivery of parathyroid hormone agents
US7541140B2 (en) * 2004-06-03 2009-06-02 Scantibodies Laboratory, Inc. Assessing risk for kidney stones using parathyroid hormone agonist and antagonist
CA2628945A1 (en) * 2005-11-10 2007-05-24 Board Of Control Of Michigan Technological University Black bear parathyroid hormone and methods of using black bear parathyroid hormone
EP2054077A4 (en) * 2006-08-04 2010-10-13 Gen Hospital Corp POLYPEPTIDE DERIVATIVES OF PARATHYROID HORMONE (PTH)
CA2694667C (en) 2007-08-01 2018-10-30 The General Hospital Corporation Screening methods using g-protein coupled receptors and related compositions
BRPI0721943A2 (pt) * 2007-08-09 2014-03-18 Usv Ltd Processo ortogonal para purificação do hormônio da paratireoide humano recombinante (rhpth) (1-34)
US20120178900A1 (en) * 2009-08-11 2012-07-12 Biocon Limited Chromatographic processes and purified compounds thereof
CA2782640A1 (en) 2009-12-07 2011-06-16 Michigan Technological University Black bear parathyroid hormone and methods of using black bear parathyroid hormone
CN103002906B (zh) 2010-05-13 2017-12-29 总医院有限公司 甲状旁腺激素类似物及其应用
ES2833277T3 (es) 2011-06-07 2021-06-14 Asahi Kasei Pharma Corp Preparación liofilizada que contiene PTH de alta pureza y método para producirla
CN102993293B (zh) * 2012-12-05 2014-05-07 深圳翰宇药业股份有限公司 一种特立帕肽醋酸盐的纯化方法
LU100168B1 (en) 2017-04-12 2018-10-15 Michael Pazianas Prevention of Bone and Mineral Disorders by Restoring Calcium and Phosphate Homeostasis in Patients Suffering from Chronic Kidney Disease
KR20220160676A (ko) 2020-03-30 2022-12-06 쓰촨 루저우 부창 바이오-파마슈티컬 컴퍼니 리미티드 인간 부갑상선 호르몬(pth)의 제형 및 그 제조 방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3886132A (en) * 1972-12-21 1975-05-27 Us Health Human parathyroid hormone
US5223407A (en) * 1988-08-31 1993-06-29 Allelix Inc. Excretion of heterologous proteins from e. coli
WO1991005050A1 (en) * 1989-09-29 1991-04-18 Her Majesty In Right Of Canada As Represented By The National Research Council Of Canada Synthesis of mature human parathyroid hormone

Also Published As

Publication number Publication date
DE69224858D1 (de) 1998-04-30
AU1604992A (en) 1993-03-11
IL101829A0 (en) 1992-12-30
IL119840A0 (en) 1997-03-18
DE69224858T2 (de) 1998-07-23
CA2068438C (en) 1996-11-12
KR970007755B1 (en) 1997-05-16
DK0515228T3 (da) 1998-09-28
NZ242855A (en) 1994-04-27
NO2006013I2 (no) 2009-12-07
JPH0687897A (ja) 1994-03-29
IL119840A (en) 2005-08-31
JP2563726B2 (ja) 1996-12-18
NO922000D0 (no) 1992-05-21
EP0515228B1 (en) 1998-03-25
AU639856B2 (en) 1993-08-05
ZA923735B (en) 1993-01-27
EP0515228A3 (fi) 1994-05-04
HK1004340A1 (en) 1998-11-20
NO304190B1 (no) 1998-11-09
US5208041A (en) 1993-05-04
EP0515228A2 (en) 1992-11-25
NO922000L (no) 1992-11-24
FI106802B (fi) 2001-04-12
ATE164394T1 (de) 1998-04-15
ES2115642T3 (es) 1998-07-01
FI922356A0 (fi) 1992-05-22
NO2006013I1 (no) 2006-11-06
CA2068438A1 (en) 1992-11-24
IE921672A1 (en) 1992-12-02
IL101829A (en) 1999-12-31

Similar Documents

Publication Publication Date Title
FI922356A (fi) Vaesentligen rent humant paratyroidhormon
DE3876273D1 (de) Isoelektrisches fokussierverfahren sowie einrichtung zur durchfuehrung dieses verfahrens.
DE3680997D1 (de) Einrichtung zur als sprache empfundenen rueckkopplung.
DE3778438D1 (de) Referenzspannung fuer transistorkonstantstromquelle.
DE3682249D1 (de) Verfahren zur bildbearbeitung und geraet zur bilderzeugung.
ATE157100T1 (de) Antikoerperfragmente in therapie
ATE72833T1 (de) Rinder-prowachstums- und -wachstumshormon.
DE3853301D1 (de) Verfahren und Vorrichtung zur Positionierung von Vorlagen in Bildabtastern.
FR2671631B1 (fr) Appareil automatique d'electrophorese.
ATE148923T1 (de) Funktioneller test und reagenz zur bestimmung von fibrinogen
DE3778483D1 (de) Vorrichtung fuer linearlager mit vollstaendiger nachstellung und entsprechendes verfahren.
DE3662077D1 (de) A lorgnette frame
DE3868837D1 (de) Kontrollvorrichtung fuer lineare dimensionen von teilen.
DE69109700D1 (de) Kapillarelektrophoreseverfahren.
IT8467198A1 (it) Metodo e dispositivo per il controllo dei processi di saldatura mediante l'analisi della luminosita' generata durante il processo.
DE69331260D1 (de) Vorrichtung zur Kodierung von umbeweglichen Bildern und entsprechende Dekodiervorrichtung
DE3774293D1 (de) Geraet und methode zur positionierung von magnetischen koepfen.
DE59208798D1 (de) Vorrichtung zur erzeugung von zwischenspannungen
DE3668789D1 (de) Vorrichtung und destillationsverfahren.
FR2592525B1 (fr) Procede de fabrication d'un transistor lateral integre et circuit integre le comprenant
FR2653560B2 (fr) Procede et appareil automatique d'electrophorese.
DE69126519D1 (de) Kapillarelektrophoreseverfahren und Vorrichtung dafür
ATE84481T1 (de) Verfahren und vorrichtung zum banderolieren von waren.
DE3769613D1 (de) Verfahren und einrichtung zur lokalisierung von teilen.
IT8822532A0 (it) Sistema per l'analisi dei circuiti all'arseniuro di gallio.

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: ALLELIX BIOPHARMACEUTICALS INC.

PC Transfer of assignment of patent

Owner name: NPS PHARMACEUTICALS, INC.

Free format text: NPS PHARMACEUTICALS, INC.

MA Patent expired